South African scientists identified a new version of the coronavirus this week that they say is behind a recent spike in COVID-19 infections in the country's most populous province. In a statement on ...
Moderna’s bivalent COVID-19 vaccine has bettered the antibody response of Spikevax against omicron when given as a booster, offering encouragement to the biotech as it races toward phase 2/3 data that ...
Beta-vax: Sanofi, GSK hail phase 3 omicron win to throw down gauntlet in COVID-19 vaccine format war
After lagging the leaders in the original COVID-19 vaccine race, Sanofi and GSK have now claimed a first in the push to protect people from omicron. The partners hailed the first successful efficacy ...
(Reuters) - Moderna Inc on Tuesday said a COVID-19 booster designed to target the Beta variant as well as the original coronavirus generated a better immune response against a number of virus variants ...
People hospitalized with the omicron variant of COVID-19 tend to be in the hospital a shorter period of time, have less need for supplemental oxygen and generally don't progress as frequently to ...
Drugmakers are racing to develop new vaccines intended to target the omicron variant, a coronavirus strain that has mutations that suggest it could evade immunity provided by vaccination or natural ...
South African scientists identified a new version of the coronavirus this week that they say is behind a recent spike in COVID-19 infections in the country's most populous province. In a statement on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback